Reach
Serving all 50 states, as our pharmacy partners and state rules allow.
You fill orders only for the states where you hold a pharmacy license that we have verified.
For pharmacy partners
SiriusRx connects licensed practices with licensed partner pharmacies. Practices order through our platform, and our order desk routes each order to the partner pharmacy that makes that product.
SiriusRx is not a pharmacy and is not a prescriber. A compounded medicine is not FDA-approved.

Why partner with us
Where orders come from, what they are, and how they reach your pharmacy.
Serving all 50 states, as our pharmacy partners and state rules allow.
You fill orders only for the states where you hold a pharmacy license that we have verified.
Patient specific prescriptions from licensed practices, for the items on your approved formulary.
The platform lists only products that have a documented, lawful compounding pathway today.
Orders are sent electronically to your pharmacy system through LifeFile, one submission per pharmacy with only your items.
There is no separate SiriusRx portal login to manage.
How it works
What we check, what you receive, and how you are paid.
A SiriusRx platform admin checks each state license a pharmacy holds against the issuing board's records, and the check is recorded. A pharmacy is not activated to receive orders until its license is verified.
Every catalog item is checked against our restricted list. An item that matches is not offered and cannot be ordered until a platform admin reviews and clears it.
A patient specific prescription, signed by the patient's own licensed provider, delivered through LifeFile.
Your pharmacist decides in professional judgment whether to fill it.
The patient pays securely in the platform when the order is placed.
SiriusRx pays the partner pharmacy for the orders it fills.
Onboarding
A pharmacy receives orders only after every requirement below is met.
A current pharmacy license for each state you will ship to. One SiriusRx admin enters it, and a second admin checks it against the issuing board's records. A pharmacy is not activated until a license is verified.
A business associate agreement, signed before activation, because orders carry patient information. HHS explains business associates in its guidance linked below.
Your formulary and prices as a CSV file. One SiriusRx admin proposes it and a different admin approves it before it is in force. Each item is checked against our restricted list.
Your LifeFile account details, so orders can reach your pharmacy system. Please never send passwords or other credentials by email.
We also ask about accreditation you hold, such as accreditation from the National Association of Boards of Pharmacy, and about your compounding quality practices. A second SiriusRx admin checks what you provide.
How orders work
When the patient has paid, the order is sent to you through LifeFile. It carries a patient specific prescription signed by the patient's own licensed provider. Your pharmacist decides in professional judgment whether to fill it.
You may decline an order before you accept it. The patient is not charged for a part you decline.
Status updates you send back through LifeFile, such as accepted, shipped and delivered, are recorded on the order. Practices and patients ask the SiriusRx order desk about status, not your pharmacy.
Before you accept an order, the prescribing provider or the patient may cancel it, and SiriusRx passes the cancellation to you. After you accept your part, only your pharmacy may cancel it, or SiriusRx support in an exception, and the patient is refunded for that part automatically. A shipped order cannot be canceled. Every cancellation records a reason.
The patient pays securely in the platform when the order is placed. SiriusRx pays your pharmacy for the orders it fills.
Questions about an order come to the SiriusRx order desk at hello@siriushealthrx.com. Please do not send patient or health information by email.
Compliance and quality
Links to the agencies and standards bodies themselves. Each opens on the source's own site, and we reproduce none of it.
FDA's starting point for compounding law, policy, guidance and safety information.
FDA's list of compounding guidance documents, proposed rules and notices, by date issued.
FDA's record of compounding inspections, recalls and enforcement, including warning letters.
FDA's index of the warning letters it issues.
FDA's program for safety information and adverse event reporting.
The USP chapter on nonsterile compounding. We name and link it; we do not reproduce it.
The USP chapter on sterile compounding. We name and link it; we do not reproduce it.
Contact details for each state board of pharmacy, the authority for licensure in its state.
The DEA's primary source for registration and controlled substance rules.
Peptide handling resources
We do not publish storage instructions, beyond use dates, dosing or clinical guidance. They come from the USP chapters, your state's rules and the product's own information. These links go to the primary sources.
Storage and beyond use dating for sterile preparations are set out in this chapter and in your state's rules.
The same for nonsterile preparations.
FDA's lists and categories for bulk drug substances, the place to check a substance's regulatory status.
FDA's training and resources on compounding quality.
The National Library of Medicine's index of biomedical literature, for primary research.
Regulatory updates
Short summaries in our own words. Each one links to its source, which is the authority if anything here differs.
FDA proposed not to place semaglutide, tirzepatide and liraglutide on the 503B bulks list, the list of bulk drug substances outsourcing facilities may use, finding no clinical need. FDA said it would consider public comments before a final determination. Check the source for the current status.
FDA issued final guidance, “Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act.” It describes FDA's interim policy for compounders that are not outsourcing facilities while FDA develops the 503A bulks list, and it replaces the 2017 guidance of the same title.
Source: U.S. Food and Drug Administration, guidance document
FDA proposed a rule setting criteria for lists of drug products that present demonstrable difficulties for compounding under sections 503A and 503B, and naming the first three categories on those lists.
Source: U.S. Food and Drug Administration, Human Drug Compounding Policies and Rules
Resource library
The national professional association for pharmacists. Linked as a resource; SiriusRx is not a member and is not affiliated.
The federal agency that regulates drugs, including compounding under sections 503A and 503B.
The federal department that includes FDA and administers HIPAA.
HHS guidance on business associates under HIPAA.
A free index of biomedical and life sciences literature.
The association of the state boards of pharmacy.
Who does what
Your practice's own licensed provider sees the patient, decides whether a medication is right, and signs every prescription in the platform. Medical questions go to your provider.
A licensed partner pharmacy reviews each signed, patient specific prescription and decides in its own professional judgment whether to fill it. It prepares, labels and ships the medication.
We run the platform and the order desk. We check each order and route it to the partner pharmacy that makes the product. Patients pay securely in the platform, and SiriusRx pays the partner pharmacy. Order questions come to us.
What we don't do: SiriusRx is not a pharmacy and is not a prescriber. We do not give medical advice, and we do not market to your patients.
Contact
Pharmacy partners and pharmacies interested in partnering can reach us through our contact form, or email hello@siriushealthrx.com. Please do not send patient or health information.